Published by Duncan Ferris on 14th June 2019
(Sharecast News) - Frontier IP's portfolio company Exscientia on Friday expanded its presence in Asia after it entered an AI drug discovery partnership with Shanghai-headquartered GT Apeiron Therapeutics.
URL: http://www.digitallook.com/dl/news/story/29170410/...